Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 4, Issue 3, Pages 235-240Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2004.01.008
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL 67664, HL 33009] Funding Source: Medline
- NIEHS NIH HHS [ES 00002] Funding Source: Medline
Ask authors/readers for more resources
Data summarized in this review indicate that airway smooth muscle cells express receptors for cytokines derived from CD4(+) T cells and that these cytokines, particularly interleukin-13, can act directly on airway smooth muscle cells leading to changes in contractile and relaxant responses, proliferation, and the ability of smooth muscle cells to generate chemokines such as eotaxin and TARC. Moreover, the interleukin-4 receptor-alpha genotype of airway smooth muscle appears to be an important determinant of its response to Th2 cytokines. Understanding the mechanistic basis for the interactions between these cytokines and airway smooth muscle might suggest new avenues for therapeutic intervention in asthma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available